J., Sanz, L., Angulo, Y., Lomonte, B
Possible role of l-carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic-Fructose-supplemented rats
We're seeing new medications in development, potential combination therapies, and hopefully, better insurance coverage over time
In a further embodiment of the present invention the GLP-1 peptide to be purified is selected from GLP-1 (7-37), GLP-1 (7-36) amide as well as analogues and derivatives thereof, in particular but not limited to human glucagon-like peptide-1, In a further embodiment of the present invention the GLP-1 related impurities to be removed are selected from but not limited to truncated forms, all kinds of extended forms (extra amino acids, various derivatives including esters etc.), deamidated forms, incorrectly folded forms, forms with undesired glycosylation including sialylation
Moving from 0.25 mg to 0.50 mg and from 0.50 mg to 1.0 mg represent the steepest relative dose jumps in the titration schedule (100% increases each time)